ScreenPro Security Inc. (SCRSF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 856.57 Thousand USD | -233.09% |
| 2022 | -124.82 Thousand USD | 50.91% |
| 2021 | -254.24 Thousand USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 72.61 Thousand USD | 1224.91% |
| 2024 Q2 | 86 Thousand USD | 169.53% |
| 2023 Q3 | 34.98 Thousand USD | 114.19% |
| 2023 Q2 | -246.45 Thousand USD | -0.32% |
| 2023 FY | -415.77 Thousand USD | -233.09% |
| 2023 Q1 | -245.66 Thousand USD | -147.74% |
| 2023 Q4 | 5611.00 USD | -83.96% |
| 2022 Q4 | 514.64 Thousand USD | 186.76% |
| 2022 FY | -124.82 Thousand USD | 50.91% |
| 2022 Q3 | -593.17 Thousand USD | 3.45% |
| 2022 Q2 | -614.39 Thousand CAD | -203.15% |
| 2022 Q1 | 595.65 Thousand CAD | 178.96% |
| 2021 Q2 | 990.92 Thousand CAD | 260.77% |
| 2021 Q1 | 274.66 Thousand CAD | 0.0% |
| 2021 Q3 | 1.29 Million CAD | 30.87% |
| 2021 FY | -254.24 Thousand USD | 0.0% |
| 2021 Q4 | -754.4 Thousand USD | -158.17% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 543.821% |
| Arrayit Corporation | 2.57 Million USD | 66.736% |
| Atlantic International Corp. | -154.23 Thousand USD | 655.373% |
| Biocept, Inc. | -2.58 Million USD | 133.175% |
| Bioqual, Inc. | 7.42 Million USD | 88.47% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -210.353% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 99.987% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | 52.256% |
| iMD Companies, Inc. | -23.63 Thousand USD | 3723.869% |
| IDenta Corp. | 662.97 Thousand USD | -29.202% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 96.283% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -1004.245% |
| InVitro International | 635.98 Thousand USD | -34.685% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | 86.948% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | 21.608% |
| NovelStem International Corp. | 12 Thousand USD | -7038.117% |
| Optigenex Inc. | -102.96 Thousand USD | 931.9% |
| PharmChem, Inc. | 3.9 Million USD | 78.061% |
| Proteome Sciences plc | 2.09 Million USD | 59.145% |
| Response Genetics, Inc | 3.94 Million USD | 78.271% |
| Rennova Health, Inc. | 6.26 Million USD | 86.335% |
| RushNet, Inc. | 1.1 Million USD | 22.455% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 312.156% |
| Todos Medical Ltd. | 4.31 Million USD | 80.126% |